Karl Ploessl

8PUBLICATIONS
3CO-AUTHORS
Gene and molecular therapyPharmaceutical delivery technologiesPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsAnimal growth and development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 10, 2024
Novel [68Ga/177Lu]Ga/Lu-AZ-093 as PSMA-Targeting Agent for Diagnosis and Radiotherapy.

Ran Wang, Wenbin Jin, Yang Luo

|Mar 07, 2024
Theranostic Agent Targeting Bone Metastasis: A Novel [68Ga]Ga/[177Lu]Lu-DOTA-HBED-bisphosphonate.

Wenbin Jin, Ruiyue Zhao, Ran Wang

|Sep 05, 2023
Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy.

Zhihao Zha, Karl Ploessl, Seok Rye Choi

|Mar 21, 2023
[68Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake.

Haiyan Hong, Zhihao Zha, Ruiyue Zhao

|Sep 14, 2022
New PSMA-Targeting Ligands: Transformation from Diagnosis (Ga-68) to Radionuclide Therapy (Lu-177).

Zhihao Zha, Seok Rye Choi, Linlin Li

|Jul 16, 2021
A New Highly Deuterated [18F]AV-45, [18F]D15FSP, for Imaging β-Amyloid Plaques in the Brain.

Hao Xiao, Seok Rye Choi, Ruiyue Zhao

Pageof 2

Frequent Collaborators

7 joint publications

Hank F Kung

3 joint publications

Lin Zhu

2 joint publications

Haiyan Hong